A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : Rb / retinoblastoma susceptibility gene

[Related PubMed/MEDLINE]
Total Number of Papers: 105
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   Rb  (>> Co-occurring Abbreviation)
Long Form:   retinoblastoma susceptibility gene
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2011 Human retinoblastoma binding protein 9, a serine hydrolase implicated in pancreatic cancers. RBBP9
2010 The simian virus 40 large tumor antigen activates cSrc and requires cSrc for full neoplastic transformation. ---
2006 Formation of the G-quadruplex and i-motif structures in retinoblastoma susceptibility genes (Rb). 2AP, CD
2006 Structural and functional characterizations of the G-quartet and i-motif elements in retinoblastoma susceptibility genes (Rb). m8G
2005 [Achieving pathogenesis understanding of ocular diseases by deciphering the underlying molecular pathways]. ---
2004 Transforming growth factor-beta antagonizes alveolar type II cell proliferation induced by keratinocyte growth factor. CDK, KGF, TGF
2003 Minimal effects of dietary restriction on neuroendocrine carcinogenesis in Rb+/- mice. AL
2003 The retinoblastoma protein interacts with Bag-1 in human colonic adenoma and carcinoma derived cell lines. ---
2002 Oncogenes, growth factors, receptor expression and proliferation markers in digestive neuroendocrine tumours. A critical reappraisal. dNETs
10  2002 The molecular genetics of therapeutic resistance in malignant astrocytomas. MA
11  2001 The physiology of p16(INK4A)-mediated G1 proliferative arrest. CDKs, INK4A
12  2000 A paradigm for cancer treatment using the retinoblastoma gene in a mouse model. ---
13  2000 Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers. mAb, MS-SNuPE, RT-PCR
14  2000 Identification of a novel partner of RNA polymerase II subunit 11, Che-1, which interacts with and affects the growth suppression function of Rb. DOX, Pol II
15  2000 Rb and p130 regulate RNA polymerase I transcription: Rb disrupts the interaction between UBF and SL-1. ---
16  2000 Retinoblastoma susceptibility protein, Rb, possesses multiple BRCT-Ws, BRCA1 carboxyl-terminus-related W regions with DNA break-binding activity. ---
17  1999 A cyclin D-Cdk4 activity required for G2 phase cell cycle progression is inhibited in ultraviolet radiation-induced G2 phase delay. ---
18  1999 Rb independent inhibition of cell growth by p15(INK4B). CDKI
19  1999 RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice. ---
20  1999 Recruitment of the retinoblastoma protein to c-Jun enhances transcription activity mediated through the AP-1 binding site. ---
21  1999 The adenomatous polyposis coli protein and retinoblastoma protein are cleaved early in apoptosis and are potential substrates for caspases. APC, PARP
22  1998 Differential expression of p53 tumor suppressor protein and IL-2 in activated T cells from elderly humans. IL-2, mAb, PMA
23  1998 p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma. pRb
24  1998 p16INK4A participates in a G1 arrest checkpoint in response to DNA damage. CDK4
25  1998 p53-independent role of MDM2 in TGF-beta1 resistance. TGF-beta
26  1998 The role of protein kinase C in G1 and G2/M phases of the cell cycle (review). CDKs, PKC
27  1997 Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL). ATL, CDKIs, CDKs, PCR-SSCP
28  1997 RNA polymerase III transcription repressed by Rb through its interactions with TFIIIB and TFIIIC2. Pol III
29  1997 The temporal relationship between protein phosphatase, ICE/CED-3 proteases, intracellular acidification, and DNA fragmentation in apoptosis. FMK, PARP
30  1996 Alterations of the p53, Rb and MDM2 genes in osteosarcoma. ---
31  1996 Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukaemia. ALL
32  1996 Genes in the RB pathway and their knockout in mice. ---
33  1996 Plant cells contain a novel member of the retinoblastoma family of growth regulatory proteins. ---
34  1996 The block of adipocyte differentiation by a C-terminally truncated, but not by full-length, simian virus 40 large tumor antigen is dependent on an intact retinoblastoma susceptibility protein family binding domain. SV40, SVLT1-121
35  1996 The Rb family contains a conserved cyclin-dependent-kinase-regulated transcriptional repressor motif. CDKs
36  1996 The retinoblastoma gene product activates transcription of the hepatitis B virus pregenomic promoter through the Sp1 binding sites. HBV
37  1996 The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability. TLCK, TPCK
38  1996 Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas. ---
39  1996 Wild-type and mutant retinoblastoma protein in paraffin sections. pRb
40  1995 Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product. UBF
41  1995 Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. MEFs
42  1995 Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. LOH
43  1995 Growth enhancement of normal human keratinocytes by the antisense oligonucleotide of retinoblastoma susceptibility gene. RT-PCR
44  1995 Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. CDKs, TGF-beta
45  1995 Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. NSCLC, SCLC
46  1995 The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2. ---
47  1995 The retinoblastoma gene product negatively regulates transcriptional activation mediated by the human cytomegalovirus IE2 protein. HCMV
48  1994 Characterization of a chicken cDNA encoding the retinoblastoma gene product. ---
49  1994 Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's limited transforming activity but does eliminate viral viability. JCV, MSTn, SV40
50  1994 Defective human retinoblastoma protein identified by lack of interaction with the E1A oncoprotein. ---
51  1994 Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method. SCLC
52  1994 Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter. ---
53  1994 Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells. MK, TGF-beta1
54  1994 Lack of detection of p53 expression in retinoblastoma tumor cells. ---
55  1994 Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression. ---
56  1994 Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. ---
57  1994 Role of the retinoblastoma protein in cell cycle arrest mediated by a novel cell surface proliferation inhibitor. HSBP
58  1994 The retinoblastoma gene is involved in malignant progression of astrocytomas. LOH, SSCP
59  1993 Adenovirus-E1A proteins transform cells by sequestering regulatory proteins. ---
60  1993 Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. NSCLCs
61  1993 Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease. ---
62  1993 Nasopharyngeal carcinoma shows no detectable retinoblastoma susceptibility gene alterations. NPC, RT-PCR
63  1993 Rb may act as a transcriptional co-activator in undifferentiated F9 cells. F9EC
64  1993 Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells. DMSO, RA
65  1993 Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction. CAS, PBLs, PHA, PWM
66  1993 Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells. ---
67  1993 [Tumor suppressor genes and their role in abnormal production of leukocytes (leukemogenesis)]. ---
68  1992 Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. ---
69  1992 Cell cycle regulation of retinoblastoma protein phosphorylation. ---
70  1992 Cell cycle regulation of the human cdc2 gene. UNC
71  1992 E1A-responsive elements for repression of rat fibronectin gene transcription. CAT, FN
72  1992 Expression, purification, and functional characterization of adenovirus 5 and 12 E1A proteins produced in insect cells. Ad
73  1992 Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. ---
74  1992 Identification of a growth suppression domain within the retinoblastoma gene product. ---
75  1992 Inactivation of the retinoblastoma gene in acute myelogenous leukaemia. AML
76  1992 Purification and characterization of a functionally homogeneous 60-kDa species of the retinoblastoma gene product. ---
77  1992 Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. pRb
78  1992 The retinoblastoma gene product suppresses neu oncogene-induced transformation via transcriptional repression of neu. ---
79  1992 The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. ---
80  1992 Transformation and radiosensitivity of human diploid skin fibroblasts transfected with SV40 T-antigen mutants defective in RB and P53 binding domains. ---
81  1992 Transforming growth factor-beta inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. TGF-beta
82  1992 [Abnormalities of the retinoblastoma susceptibility gene (RB) in hematologic malignancies]. ---
83  1991 A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product. ---
84  1991 Changes in phosphorylation of myc oncogene and RB antioncogene protein products during growth arrest of the murine lymphoma WEHI 231 cell line. GaMIg
85  1991 Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. PD
86  1991 Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells. ---
87  1991 Overexpression of the retinoblastoma gene in a familial adrenocortical carcinoma. ---
88  1991 Retinoblastoma protein and simian virus 40-dependent immortalization of human fibroblasts. SV40
89  1990 Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. ---
90  1990 Dissociation of Rb-binding and anchorage-independent growth from immortalization and tumorigenicity using SV40 mutants producing N-terminally truncated large T antigens. ---
91  1990 Expression of the human retinoblastoma gene product pp110RB in insect cells using the baculovirus system. ---
92  1990 The molecular genetics of retinoblastoma. ---
93  1990 Tumor suppressor genes. ---
94  1990 Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. AMV
95  1989 Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. ---
96  1989 Studies of the retinoblastoma gene in human sarcomas. ---
97  1989 SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. ---
98  1988 A case of synovial sarcoma with abnormal expression of the human retinoblastoma susceptibility gene. ---
99  1988 Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. ---
100  1988 Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. ---